These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 23881695)

  • 21. Tranexamic acid for upper gastrointestinal bleeding.
    Bennett C; Klingenberg SL; Langholz E; Gluud LL
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006640. PubMed ID: 25414987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total joint arthroplasty: A meta-analysis of randomized controlled trials.
    Zhang XQ; Ni J; Ge WH
    Int J Surg; 2017 Feb; 38():15-20. PubMed ID: 27913237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined use of intravenous and topical versus intravenous tranexamic acid in primary total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
    Li JF; Li H; Zhao H; Wang J; Liu S; Song Y; Wu HF
    J Orthop Surg Res; 2017 Feb; 12(1):22. PubMed ID: 28153031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement.
    Alshryda S; Sukeik M; Sarda P; Blenkinsopp J; Haddad FS; Mason JM
    Bone Joint J; 2014 Aug; 96-B(8):1005-15. PubMed ID: 25086114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing and volume of fluid administration for patients with bleeding.
    Kwan I; Bunn F; Chinnock P; Roberts I
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD002245. PubMed ID: 24599652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous versus topical tranexamic acid administration in primary total knee arthroplasty: a meta-analysis.
    Shin YS; Yoon JR; Lee HN; Park SH; Lee DH
    Knee Surg Sports Traumatol Arthrosc; 2017 Nov; 25(11):3585-3595. PubMed ID: 27417102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.
    Chen TP; Chen YM; Jiao JB; Wang YF; Qian LG; Guo Z; Ma Z; Han CY; Shi TH
    J Orthop Surg Res; 2017 Jan; 12(1):11. PubMed ID: 28103911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis.
    Ker K; Edwards P; Perel P; Shakur H; Roberts I
    BMJ; 2012 May; 344():e3054. PubMed ID: 22611164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is combined use of intravenous and intraarticular tranexamic acid superior to intravenous or intraarticular tranexamic acid alone in total knee arthroplasty? A meta-analysis of randomized controlled trials.
    Mi B; Liu G; Lv H; Liu Y; Zha K; Wu Q; Liu J
    J Orthop Surg Res; 2017 Apr; 12(1):61. PubMed ID: 28420413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood Loss and Transfusion After Topical Tranexamic Acid Administration in Primary Total Knee Arthroplasty.
    Wang H; Shen B; Zeng Y
    Orthopedics; 2015 Nov; 38(11):e1007-16. PubMed ID: 26558665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intravenous versus topical tranexamic acid in primary total hip and knee arthroplasty: An updated meta-analysis.
    Xie J; Hu Q; Huang Q; Ma J; Lei Y; Pei F
    Thromb Res; 2017 May; 153():28-36. PubMed ID: 28319822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis.
    Cheriyan T; Maier SP; Bianco K; Slobodyanyuk K; Rattenni RN; Lafage V; Schwab FJ; Lonner BS; Errico TJ
    Spine J; 2015 Apr; 15(4):752-61. PubMed ID: 25617507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined versus single application of tranexamic acid in total knee and hip arthroplasty: A meta-analysis of randomized controlled trials.
    Peng Zhang MM; Jifeng Li MM; Xiao Wang MM
    Int J Surg; 2017 Jul; 43():171-180. PubMed ID: 28602763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
    Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
    Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.